OR WAIT null SECS
August 02, 2010
Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
July 02, 2010
More information may be released to improve public understanding of regulatory policies.
May 02, 2010
Manufacturers will pay new fees but anticipate expanded drug use and safeguards for innovation.
April 02, 2010
FDA lacks resources to manage expanding postmarketing responsibilities.
March 02, 2010
FDA modernizes information systems, expands access to drug safety and use information.
February 02, 2010
Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
December 02, 2009
Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
November 02, 2009
The heightened focus on risk raises concerns about delays in approving new drugs.
October 02, 2009
Strict enforcement, new rules, and organizational changes signal an activist tone.
September 02, 2009
Health crises generate support for new vaccines and treatments for diseases found in developing nations.